LeeAnn Levesque
Public Communications Contact chez ANALOGIC CORPORATION
Postes actifs de LeeAnn Levesque
Sociétés | Poste | Début | Fin |
---|---|---|---|
ANALOGIC CORPORATION | Public Communications Contact | - | - |
Corporate Officer/Principal | 01/11/2020 | - | |
ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Historique de carrière de LeeAnn Levesque
Anciens postes connus de LeeAnn Levesque
Sociétés | Poste | Début | Fin |
---|---|---|---|
SureScan Corp.
SureScan Corp. Aerospace & DefenseElectronic Technology SureScan Corp. manufactures security scanning devices. It offers x1000 TSA Certified and ECAC EDS Std 3 system, designed for high speed screening of baggage and packages. The company was founded on May 10, 2004 and is headquartered in Endicott, NY. | Directeur Général | - | - |
President | - | - |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
President | 1 |
Sectorielle
Health Technology | 3 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
SureScan Corp.
SureScan Corp. Aerospace & DefenseElectronic Technology SureScan Corp. manufactures security scanning devices. It offers x1000 TSA Certified and ECAC EDS Std 3 system, designed for high speed screening of baggage and packages. The company was founded on May 10, 2004 and is headquartered in Endicott, NY. | Electronic Technology |
Analogic Corp.
Analogic Corp. Medical SpecialtiesHealth Technology Analogic Corp. engages in the business of designing, development manufacturing, and supporting technically advanced and cost-effective imaging and detection, and power and automation solutions for security, healthcare, and other high-end industrial markets. The firm is also involved in the innovation in the field of computed tomography. The company was founded by Bernard Marshall Gordon on November 27, 1967 and is headquartered in Peabody, MA. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
- Bourse
- Insiders
- LeeAnn Levesque
- Expérience